The Geneva University Hospitals (HUG), the University of Geneva (UNIGE) and their spin-off Endotelix have created a possible target molecule for the antibodies responsible for antiphospholipid syndrome. This discovery will ...
Nov 1, 2022
0
4
Researchers at Vanderbilt University Medical Center have found that the change in a single letter of the genetic code promotes, in a mouse model, the development of inflammation, high blood pressure and resulting kidney damage.
Oct 21, 2022
0
12
Pediatric encephalopathies of genetic origin cause severe motor and intellectual disabilities from birth. One of these diseases, first identified in 2013, is caused by mutations in the GNAO1 gene. In order to understand the ...
Oct 10, 2022
0
60
Rendering the invisible visible is among scientists' favorite challenges.
Sep 26, 2022
0
44
Parkinson's disease and Lewy body dementia belong to a family of neurodegenerative disorders called synucleinopathies because they are caused by the pathological accumulation of protein alpha-synuclein into structures called ...
Apr 29, 2022
0
78
The hepatitis C virus (HCV) is a genetically highly variable virus that mutates extensively. An effective vaccine would therefore need to evoke broadly neutralizing antibodies that not only neutralize one HCV strain, but ...
Jan 31, 2022
0
5
The nomination deadline to recognize transformative discoveries for the Nobel prize in physiology or medicine is fast approaching. These nominations are by invitation only and are due by the end of January.
Jan 21, 2022
0
2
Scientists on Thursday unveiled the most exhaustive database yet of the proteins that form the building blocks of life, in a breakthrough observers said would "fundamentally change biological research".
Jul 22, 2021
0
2
A small, light-activated molecule recently tested in mice represents a new approach to eliminating clumps of amyloid protein found in the brains of Alzheimer's disease patients. If perfected in humans, the technique could ...
Apr 13, 2021
1
842
Inhibiting a novel protein variant within glioma stem cells may be a promising therapeutic approach to treat glioblastoma, according to a Northwestern Medicine study published in Nature Cell Biology.
Apr 6, 2021
0
45
